Two sustained-release dosage forms, enteric-coated granules and tablets compressed from enteric-coated granules, were prepared for a long-acting effect of the prodrug clorprenaline pamoate.Using the dissolution rate in vitro and the antiasthmatic activity in vivo as indexes, a comparison was made between the sustained-release effects of the two dosage forms. The tablet made from enteric-coated granules was shown to be an ideal sustained-release dosage form. The tablet was shown through clinical tests, as expected, to have insignificant side-effects and to prolong the antiasthmatic activity to about 12 hours.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
'/%3e%3cuse xlink:href='%23a' transform='rotate(60)'/%3e%3ccircle r='17' fill='%23000095'/%3e%3ccircle r='15' fill='%23fff'/%3e%3c/svg%3e)